... total raised to over $1 billion). In the field of nuclear fusion, European companies have set a new funding record (around €290 million in the first half of 2025), while American projects lead in mega rounds (for instance, Commonwealth Fusion Systems raised around $1 billion). Biotechnology and medtech startups are also accumulating significant capital from venture funds. For example, American startup Centivax secured $45 million for developing a universal flu vaccine. The cybersecurity segment remains one of the market's drivers (notably, recalling недавно multi-billion deals in this ...

... 2025: New IPOs, Record Investments, and M&A Deals As of early August 2025, the global venture capital market is showing a robust recovery after several years of decline. Investors worldwide are once again actively funding technology companies: record capital is being raised, and startup plans for IPOs are once more in the spotlight. Major funds and corporations have resumed large-scale venture investments, initiating the launch of new funds and programs; governments across various countries are increasing support ...

... director Mira Murati) raised about $2 billion at an early stage, with a valuation of ~$12 billion — an unprecedented appetite from investors for this young project. Elon Musk's project xAI closed a record funding round: approximately $5 billion in equity capital and another $5 billion in debt instruments were raised, providing the company with colossal resources for developing its AI platform and data center infrastructure. Industry insiders estimate that xAI's value now exceeds $100 billion, placing it among the most valuable private firms globally. Another ...

... raised funds to more than $1 billion. In the field of nuclear fusion, European companies set a new record for funding (around €290 million in the first half of 2025), while American projects lead in mega rounds (for example, Commonwealth Fusion Systems raised around $1 billion). Biotechnology and medtech startups are also accumulating significant capital from venture funds. For instance, the American startup Centivax secured $45 million for developing a universal flu vaccine. The cybersecurity segment remains one of the market’s drivers (consider the significant deal with Cato Networks mentioned ...

... longstanding partners of OpenAI and new major players; specifically, the Dragoneer fund contributed $2.8 billion (one of the largest sums ever invested by a single venture fund), while giants like Blackstone and TPG also participated. Such unprecedented capital raising underscores the colossal market interest in leading AI companies. It is worth noting that the ongoing investment frenzy encompasses not only AI projects themselves but also the infrastructure supporting them. For instance, the American-Israeli ...